16:02 Dec 20
Medicamen Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Medicamen Biotech Ltd.
28/100 Low Financial Strength
Quality22/100 Expensive Valuation
Valuation56/100 Technically Neutral
TechnicalSWOT
Strength
5
Weakness
10
Opportunity
0
Threat
0
664.47
Market Cap (Cr)
95.40
PE Ratio
3.08
Price to Book Ratio
47.8
RSI
6.09 %
Net Profit Margin
SWOT
Download Our App On:
